1. Home
  2. PSNY vs NEO Comparison

PSNY vs NEO Comparison

Compare PSNY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

HOLD

Current Price

$8.60

Market Cap

2.0B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$17.43

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNY
NEO
Founded
2017
2001
Country
Sweden
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
PSNY
NEO
Price
$8.60
$17.43
Analyst Decision
Sell
Strong Buy
Analyst Count
2
8
Target Price
$15.00
$13.38
AVG Volume (30 Days)
127.1K
1.7M
Earning Date
04-17-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.06
$10.63
Revenue Next Year
$47.98
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$7.07
52 Week High
$23.75
$19.76

Technical Indicators

Market Signals
Indicator
PSNY
NEO
Relative Strength Index (RSI) 21.86 57.75
Support Level $0.56 $15.72
Resistance Level $14.90 $19.76
Average True Range (ATR) 0.70 0.81
MACD -0.14 -0.04
Stochastic Oscillator 0.62 39.36

Price Performance

Historical Comparison
PSNY
NEO

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: